Clare Rock1, Kerri A Thom2, Anthony D Harris2, Shanahan Li3, Daniel Morgan2, Aaron M Milstone4, Brian Caffo5, Manjari Joshi6, Surbhi Leekha2. 1. 1Department of Medicine,Division of Infectious Diseases,Johns Hopkins University,Baltimore,Maryland. 2. 2Department of Epidemiology and Public Health,University of Maryland School of Medicine,Baltimore,Maryland. 3. 3Department of Biostatistics,Indiana University Fairbanks School of Public Health,Indianapolis,Indiana. 4. 4Department of Pediatrics,Division of Pediatric Infectious Diseases,Johns Hopkins University School of Medicine,Baltimore,Maryland. 5. 5Department of Biostatistics,Bloomberg School of Public Health,Johns Hopkins University,Baltimore,Maryland. 6. 6Division of Infectious Diseases,University of Maryland Medical Center,School of Medicine,Baltimore,Maryland.
Abstract
BACKGROUND: Central-line-associated bloodstream infection (CLABSI) rate is an important quality measure, but it suffers from subjectivity and interrater variability, and decreasing national CLABSI rates may compromise its power to discriminate between hospitals. This study evaluates hospital-onset bacteremia (HOB, ie, any positive blood culture obtained 48 hours post admission) as a healthcare-associated infection-related outcome measure by assessing the association between HOB and CLABSI rates and comparing the power of each to discriminate quality among intensive care units (ICUs). METHODS: In this multicenter study, ICUs provided monthly CLABSI and HOB rates for 2012 and 2013. A Poisson regression model was used to assess the association between these 2 rates. We compared the power of each measure to discriminate between ICUs using standardized infection ratios (SIRs) with 95% confidence intervals (CIs). A measure was defined as having greater power to discriminate if more of the SIRs (with surrounding CIs) were different from 1. RESULTS: In 80 ICUs from 16 hospitals in the United States and Canada, a total of 663 CLABSIs, 475,420 central line days, 11,280 HOBs, and 966,757 patient days were reported. An absolute change in HOB of 1 per 1,000 patient days was associated with a 2.5% change in CLABSI rate (P<.001). Among the 80 ICUs, 20 (25%) had a CLABSI SIR and 60 (75%) had an HOB SIR that was different from 1 (P<.001). CONCLUSION: Change in HOB rate is strongly associated with change in CLABSI rate and has greater power to discriminate between ICU performances. Consideration should be given to using HOB to replace CLABSI as an outcome measure in infection prevention quality assessments.
BACKGROUND: Central-line-associated bloodstream infection (CLABSI) rate is an important quality measure, but it suffers from subjectivity and interrater variability, and decreasing national CLABSI rates may compromise its power to discriminate between hospitals. This study evaluates hospital-onset bacteremia (HOB, ie, any positive blood culture obtained 48 hours post admission) as a healthcare-associated infection-related outcome measure by assessing the association between HOB and CLABSI rates and comparing the power of each to discriminate quality among intensive care units (ICUs). METHODS: In this multicenter study, ICUs provided monthly CLABSI and HOB rates for 2012 and 2013. A Poisson regression model was used to assess the association between these 2 rates. We compared the power of each measure to discriminate between ICUs using standardized infection ratios (SIRs) with 95% confidence intervals (CIs). A measure was defined as having greater power to discriminate if more of the SIRs (with surrounding CIs) were different from 1. RESULTS: In 80 ICUs from 16 hospitals in the United States and Canada, a total of 663 CLABSIs, 475,420 central line days, 11,280 HOBs, and 966,757 patient days were reported. An absolute change in HOB of 1 per 1,000 patient days was associated with a 2.5% change in CLABSI rate (P<.001). Among the 80 ICUs, 20 (25%) had a CLABSI SIR and 60 (75%) had an HOB SIR that was different from 1 (P<.001). CONCLUSION: Change in HOB rate is strongly associated with change in CLABSI rate and has greater power to discriminate between ICU performances. Consideration should be given to using HOB to replace CLABSI as an outcome measure in infection prevention quality assessments.
Authors: Deborah S Yokoe; Deverick J Anderson; Sean M Berenholtz; David P Calfee; Erik R Dubberke; Katherine D Ellingson; Dale N Gerding; Janet P Haas; Keith S Kaye; Michael Klompas; Evelyn Lo; Jonas Marschall; Leonard A Mermel; Lindsay E Nicolle; Cassandra D Salgado; Kristina Bryant; David Classen; Katrina Crist; Valerie M Deloney; Neil O Fishman; Nancy Foster; Donald A Goldmann; Eve Humphreys; John A Jernigan; Jennifer Padberg; Trish M Perl; Kelly Podgorny; Edward J Septimus; Margaret VanAmringe; Tom Weaver; Robert A Weinstein; Robert Wise; Lisa L Maragakis Journal: Infect Control Hosp Epidemiol Date: 2014-09 Impact factor: 3.254
Authors: Daniel J Sexton; Luke F Chen; Rebekah Moehring; Paul A Thacker; Deverick J Anderson Journal: Infect Control Hosp Epidemiol Date: 2012-07-24 Impact factor: 3.254
Authors: Daniel J Morgan; Jennifer Meddings; Sanjay Saint; Ebbing Lautenbach; Michelle Shardell; Deverick Anderson; Aaron M Milstone; Marci Drees; Lisa Pineles; Nasia Safdar; Jason Bowling; David Henderson; Deborah Yokoe; Anthony D Harris Journal: Clin Infect Dis Date: 2012-06-14 Impact factor: 9.079
Authors: Michael Y Lin; Bala Hota; Yosef M Khan; Keith F Woeltje; Tara B Borlawsky; Joshua A Doherty; Kurt B Stevenson; Robert A Weinstein; William E Trick Journal: JAMA Date: 2010-11-10 Impact factor: 56.272
Authors: Patricia W Stone; Andrew Dick; Monika Pogorzelska; Teresa C Horan; E Yoko Furuya; Elaine Larson Journal: Am J Infect Control Date: 2009-02-08 Impact factor: 2.918
Authors: Raymund B Dantes; Lilian M Abbo; Deverick Anderson; Lisa Hall; Jennifer H Han; Anthony D Harris; Surbhi Leekha; Aaron M Milstone; Daniel J Morgan; Nasia Safdar; Marin L Schweizer; Sharmila Sengupta; Susan K Seo; Clare Rock Journal: Infect Control Hosp Epidemiol Date: 2019-04-01 Impact factor: 3.254
Authors: Gregory M Schrank; Anna Sick-Samuels; Susan C Bleasdale; Jesse T Jacob; Raymund Dantes; Runa H Gokhale; Jeanmarie Mayer; Preeti Mehrotra; Sapna A Mehta; Alfredo J Mena Lora; Susan M Ray; Chanu Rhee; Jorge L Salinas; Susan K Seo; Andi L Shane; Gita Nadimpalli; Aaron M Milstone; Gwen Robinson; Clayton H Brown; Anthony D Harris; Surbhi Leekha Journal: Infect Control Hosp Epidemiol Date: 2022-01-28 Impact factor: 6.520
Authors: Max Masnick; Daniel J Morgan; John D Sorkin; Mark D Macek; Jessica P Brown; Penny Rheingans; Anthony D Harris Journal: Infect Control Hosp Epidemiol Date: 2017-10 Impact factor: 3.254
Authors: Viraj Ambalam; Anna C Sick-Samuels; Julia Johnson; Elizabeth Colantuoni; Avinash Gadala; Clare Rock; Aaron M Milstone Journal: Am J Infect Control Date: 2021-04-02 Impact factor: 4.303
Authors: Jonathan D Baghdadi; K C Coffey; Timileyin Adediran; Katherine E Goodman; Lisa Pineles; Larry S Magder; Lyndsay M O'Hara; Beth L Pineles; Gita Nadimpalli; Daniel J Morgan; Anthony D Harris Journal: Antimicrob Agents Chemother Date: 2021-09-07 Impact factor: 5.191